Search Results

Displaying Results 3051-3075 of 8075 "'III'"

May 11, 2026, 07:50 ET Starwood Property Trust Announces Private Offering of Sustainability Bonds

Discussion and Analysis of Financial Condition and Results of Operations"; (ii) defaults by borrowers in paying debt service on outstanding indebtedness; (iii) impairment in the value of real estate property securing the Company's loans or in which the Company invests; (iv) availability of mortgage origination

More news about: Starwood Property Trust, Inc.


May 11, 2026, 07:15 ET Hyperscale Data Announces Progress Toward Leasing AI Compute Capacity at Michigan Data Center Campus and Evaluating Long-Term Expansion Opportunities

Corp., highlight the growing strategic value being placed on scalable power infrastructure and AI-ready data center campuses," said Milton "Todd" Ault, III, Executive Chairman of Hyperscale Data. "As demand for high-density AI compute capacity continues to accelerate, management believes the market is increasingly

More news about: Hyperscale Data Inc.


May 11, 2026, 07:01 ET King's Foundation y FormationQ lanzan el programa «Crecimiento urbano armonioso»

construido.Notas para los redactoresAcerca de The King's FoundationThe King's Foundation fue fundada por el Rey Carlos III y se creó en 1990. La misión principal de esta organización benéfica es construir comunidades sostenibles y transformar vidas.Inspirada en los

More news about: FormationQ


May 11, 2026, 06:51 ET FS KKR Capital Corp. Announces First Quarter 2026 Results and Strategic Value Enhancement Actions; Declares Second Quarter 2026 Distribution of $0.42 per share

only, with the margin increasing to a range of 0.775% to 1.9% per annum from the existing range of 0.65% to 1.775%, depending on the type of loan and (iii) a reset of the minimum Shareholders' Equity (as defined in the agreement) floor to $3,750.0 million from approximately $5,048.6 million.Declaration

More news about: Future Standard


May 11, 2026, 06:50 ET United Parks & Resorts Inc. Reports First Quarter 2026 Results

these factors' likely impact, (ii) the available information with respect to these factors on which such analysis is based is complete or accurate, (iii) such analysis is correct or (iv) the Company's strategy, which is based in part on this analysis, will be successful. Except as required by law, the

More news about: United Parks and Resorts Inc.


May 11, 2026, 06:45 ET Target Hospitality Announces First Quarter 2026 Results Highlighting Sustained Momentum and Continued Execution on Strategic Transformation

evaluate its operating performance; (ii) they are among the measures used by Target Hospitality's management team to make day-to-day operating decisions, (iii) they are frequently used by securities analysts, lenders, investors and other interested parties as a common performance measure and to compare results

More news about: Target Hospitality


May 11, 2026, 03:00 ET Die King's Foundation und FormationQ starten das Programm „Harmonious Urban Growth", um Städten bei der Planung einer nachhaltigen Expansion mithilfe von Quantenoptimierung zu helfen

wider.Hinweise für die RedaktionInformationen zur The King's FoundationDie King's Foundation wurde von König Charles III. gegründet und 1990 ins Leben gerufen. Die Kernaufgabe der gemeinnützigen Organisation besteht darin, nachhaltige Gemeinschaften aufzubauen und Leben

More news about: FormationQ


May 11, 2026, 03:00 ET The King's Foundation and FormationQ Launch "Harmonious Urban Growth" Programme to Help Cities Plan Sustainable Expansion Using Quantum Optimisation

built environment.Notes to EditorsAbout The King's FoundationThe King's Foundation was founded by King CHarles III and was first formed in 1990. The charity's core mission is to build sustainable communities and transform lives.Inspired by the values of His

More news about: FormationQ


May 11, 2026, 03:00 ET The King's Foundation and FormationQ Launch "Harmonious Urban Growth" Programme to Help Cities Plan Sustainable Expansion Using Quantum Optimisation

built environment.Notes to EditorsAbout The King's FoundationThe King's Foundation was founded by King CHarles III and was first formed in 1990. The charity's core mission is to build sustainable communities and transform lives.Inspired by the values of His

More news about: FormationQ


May 11, 2026, 03:00 ET La King's Foundation et FormationQ lancent le programme Harmonious Urban Growth pour aider les villes à planifier une expansion durable à l'aide de l'optimisation quantique

bâti.Notes aux rédacteursÀ propos de la King's FoundationLa King's Foundation a été fondée par le Roi Charles III en 1990. La mission principale de l'organisation caritative est de construire des communautés durables et de transformer des vies.Inspirée par

More news about: FormationQ


May 11, 2026, 03:00 ET The King's Foundation y FormationQ lanzan el programa "Crecimiento urbano armonioso" para ayudar a las ciudades a planificar una expansión sostenible mediante la optimización cuántica

construido.Notas para los editoresAcerca de The King's FoundationThe King's Foundation fue fundada por el rey Carlos III y se constituyó por primera vez en 1990. La misión principal de la organización benéfica es construir comunidades sostenibles y transformar vidas.Inspirada

More news about: FormationQ


May 10, 2026, 20:00 ET Innovent Announces IBI363 (PD-1/IL-2α-bias Bispecific Fusion Protein) Received Third NMPA Breakthrough Therapy Designation for MSS/pMMR Metastatic Colorectal Cancer

microsatellite stable or proficient mismatch repair (MSS/pMMR) colorectal cancer (CRC) who have failed at least two prior lines of standard therapy. A Phase III clinical trial is about to initiate in China for this indication in the near term. Previously, IBI363 has received two BTDs from China's NMPA

More news about: Innovent Biologics


May 10, 2026, 09:00 ET Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP

this about: On March 13, 2026, Immutep issued a press release "announcing that the Independent Data Monitoring Committee (IDMC) for the TACTI-004 Phase III study evaluating eftilagimod alfa ('efti') in patients in 1(st) line non-small cell lung cancer has recommended the discontinuation of the trial following

More news about: THE ROSEN LAW FIRM, P. A.


May 08, 2026, 22:00 ET SES AI Corporation Securities Fraud Class Action Result of Weak Revenue Guidance and 37% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

no operational capacity; (ii) the company created the appearance of revenue by purchasing services tied to its own Molecular Universe transactions; (iii) despite its optimistic growth statements, SES AI faced significant logistics constraints in Q4 2025 that materially impacted revenue for that quarter;

More news about: Kahn Swick & Foti, LLC


May 08, 2026, 22:00 ET Gemini Space Station, Inc. Notice of May 18, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

platform; (ii) the Company had overstated its commitment to and/or the viability of growing its business through expanding its international operations; (iii) accordingly, the Company's post-IPO financial and business prospects were overstated; (iv) all of the foregoing raised a non-speculative risk that the

More news about: Kahn Swick & Foti, LLC


May 08, 2026, 20:30 ET China Innovative Drug NHWD-870 Receives Breakthrough Therapy Designation, Bringing New Hope of Survival to NUT Carcinoma Patients

multiple Chinese and global patent applications and grants in these fields. Several of the company's drug candidates are currently in Phase I, II, and III clinical trials.The NHWD-870 program, targeting the rare NUT carcinoma, has successfully completed Phase II clinical trials and holds the potential

More news about: Zhejiang Wenda Pharmaceutical Technology Co., Ltd.


May 08, 2026, 20:30 ET China Innovative Drug NHWD-870 Receives Breakthrough Therapy Designation, Bringing New Hope of Survival to NUT Carcinoma Patients

multiple Chinese and global patent applications and grants in these fields. Several of the company's drug candidates are currently in Phase I, II, and III clinical trials.The NHWD-870 program, targeting the rare NUT carcinoma, has successfully completed Phase II clinical trials and holds the potential

More news about: Zhejiang Wenda Pharmaceutical Technology Co., Ltd.


May 08, 2026, 19:22 ET Robbins Geller Rudman & Dowd LLP, Grant & Eisenhofer P.A., and Collins Shelton Blair & Wright PLLC Announce Proposed Settlement in the Forward Air Stockholder Litigation

Plaintiffs should be finally appointed as Class representatives for the Class and Plaintiffs' Counsel should be finally appointed as counsel for the Class; (iii) determine whether the proposed Settlement should be approved as fair, reasonable, and adequate to the Class and in the best interests of the Class;

More news about: Robbins Geller Rudman & Dowd LLP


May 08, 2026, 10:00 ET Entwistle & Cappucci LLP and Saxena White P.A. Announce a Proposed Settlement in the Revance Therapeutics, Inc. Securities Litigation

proposed Class should be certified for settlement purposes; (ii) the proposed Settlement should be approved by the Court as fair, reasonable and adequate; (iii) the proposed Plan of Allocation for distribution of the Settlement proceeds is fair, reasonable and adequate, and therefore should be approved; (iv) the

More news about: Entwistle & Cappucci LLP and Saxena White P.A.


May 08, 2026, 09:10 ET CANDICE BERGEN, MARIO CANTONE, KRISTIN CHENOWETH, ISAAC MIZRAHI, DONNA MURPHY, ANDREW RANNELLS TO HONOR LIZA MINNELLI AT CARNEGIE HALL

SONG AND DANCE--ONE NIGHT ONLY--AT CARNEGIE HALLLiza! at 80 is directed by Transport Group Artistic Director Jack Cummings III, five-time Drama Desk Award nominee and two-time Obie Award winner, with musical direction by Joey Chancey.  Hannah Oren serves as Creative

More news about: Transport Group


May 08, 2026, 09:00 ET Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City

manufacturing facility by CoMira Diagnostics; (ii) the ability of such facility to support manufacturing of molecular diagnostic instruments and assays; (iii) expectations regarding CoMira's positioning as an early domestic manufacturer within the Kingdom of Saudi Arabia; (iv) the potential benefits of local

More news about: Co-Diagnostics


May 08, 2026, 08:30 ET Day One and Servier Complete Enrollment in Pivotal Phase 3 FIREFLY-2 Trial of Tovorafenib as a Front-Line Treatment for Pediatric Low-Grade Glioma (pLGG)

pLGG cases worldwide and prior to the introduction of OJEMDA, there were no approved treatments for people with pLGG driven by BRAF fusions.i, iiiPediatric low-grade gliomas can be chronic and relentless, with patients suffering profound side effects from both the tumor and the treatment,

More news about: Servier Pharmaceuticals


May 08, 2026, 08:20 ET INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

with Anktiva to be cancer-free for the long term, when this has not been demonstrated"; (ii) the claim that Anktiva is a cancer vaccine was false; and (iii) ImmunityBio's Executive Chairman and Global Scientific and Medical Officer, defendant Dr. Patrick Soon-Shion, materially overstated Anktiva's capabilities.The

More news about: Robbins Geller Rudman & Dowd LLP


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.